跳至主要内容
临床试验/NCT05485077
NCT05485077招募中不适用

Colorectal Cancer Screening Cohort Study in Shougang Community Population Based on Polygene Methylation Detection Technology

Singlera Genomics Inc.1 个研究点 分布在 1 个国家目标入组 18,000 人开始时间: 2022年7月9日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
入组人数
18,000
试验地点
1
主要终点
Sensitivity and specificity of polygene methylation detection in colorectal cancer

研究概览

简要总结

This study will validate the real world results of polygene methylation detection in colorectal cancer in a large prospective community cohort. In this study, questionnaire survey and polygene methylation detection technology of colorectal cancer were used as preliminary screening methods, and colonoscopy was used as further validation examination method to screen colorectal cancer and precancerous lesions. The diagnosis and outcome of all lesions were based on colonoscopy and pathological examination.

详细描述

  1. The informed consent signed by shougang Community will be completed in the baseline period: Colorectal cancer risk factors assessment questionnaire, medical history collection, fecal immunochemical (FIT), carcinoembryonic antigen (CEA) blood test and blood bowel cancer gene methylation detection, for colorectal cancer gene methylation detection results more positive subjects and the result of the negative part of the subjects (n = 500), within 3 months after receiving the results complete colonoscopy.
  2. Follow-up at 1, 2, 3, 4, and 5 years after baseline included: ① Central follow-up at 1, 3, and 5 years: history collection, colonoscopy, FIT test, and CEA examination; ② Telephone follow-up at the 2nd and 4th years: medical history was collected; (3) Survival outcome registration was performed in the fifth year; Follow-up history was collected at 1, 2, 3, 4, and 5 years after completion of baseline, and survival outcomes were registered at 5 years.
  3. During the follow-up, the subjects were confirmed to be diagnosed with colorectal cancer by evaluation (colorectal cancer was diagnosed by colonoscopy), and the subjects who were treated after polyps or adenomas were found during colonoscopy also reached the study endpoint.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
40 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Chronological age ≥40 years;
  • Full capacity for action;
  • After enrollment, the participants were able to complete the Colorectal Cancer Risk Factor Assessment Questionnaire and the annual follow-up interviews;
  • In the course of the study, the information related to tumor diagnosis in other hospitals can be timely fed back to the researchers;

排除标准

  • History of colorectal cancer and other malignant tumors;
  • Previous colorectal resection;
  • undergoing any cancer-related treatment;
  • Patients who have received major surgical treatment such as blood transfusion or transplantation within 3 months;
  • Participate in other interventional clinical investigators within 3 months;
  • Pregnant or lactating women;
  • Have autoimmune disease, hereditary disease, mental illness/disability, etc
  • Poor compliance, unable to complete the study.

结局指标

主要结局

Sensitivity and specificity of polygene methylation detection in colorectal cancer

时间窗: assessed up to 72 months

To investigate the sensitivity and specificity of polygene methylation in the diagnosis of colorectal cancer in community population, and to evaluate its value as an auxiliary diagnosis

Negative predictive value and positive predictive value of polygene methylation in colorectal cancer

时间窗: assessed up to 72 months

To obtain the positive predictive value and negative predictive value of polygene methylation test for colorectal cancer early screening, and compare with FIT test and blood CEA test.

次要结局

未报告次要终点

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验

A Prospective Cohort Study on Colorectal Cancer... | 临床试验